Passage BIO (PASG) Other Operating Expenses (2022 - 2023)
Passage BIO (PASG) posted quarterly Other Operating Expenses of $1.6 million for Q3 2023, up 89.33% year-over-year from $825000.0 in Q3 2022, and up 1.96% quarter-over-quarter from $1.5 million in Q2 2023.
Passage BIO (PASG) Other Operating Expenses (2022 - 2023) Analysis & Trends
Passage BIO's Other Operating Expenses history runs 2 years deep, the most recent figure standing at $1.6 million for Q3 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Passage BIO | 15.05 Mn | 15.05 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 1.56 Mn |
| Jun 30, 2023 | 1.53 Mn |
| Mar 31, 2023 | 1.55 Mn |
| Sep 30, 2022 | 825,000.00 |
| Jun 30, 2022 | 270,000.00 |
| Mar 31, 2022 | 1,000.00 |